IMMUNO-HISTOCHEMICAL CHANGES TRIGGERED BY REPEATED CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MICE

Control of the Waterborne Cryptosporidiosis: Evaluation of the Protective Role of Cryptosporidium parvum Oocysts Antigen in Infected Immunocompetent and Immunosuppressed Mice

ROLE OF APOPTOSIS IN EXPERIMENTAL CRYPTOSPORIDIUM PARVUM INFECTED ALBINO MICE

DOWNREGULATION OF TOLL-LIKE RECEPTOR 4 AND ACUTE PHASE CYTOKINES MEDIATED DEXAMETHASONE IMMUNOSUPPRESSANT MECHANISM DURING CRYPTOSPORIDIUM-PARVUM INFECTION

EFFECT OF SOME MEDICINAL HERBS VERSUS NITAZOXANIDE ON CRYPTOSPORIDIUM PARVUM INFECTED IMMUNOSUPPRESSED MICE

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALING

POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

EVALUATION OF CRYPTOSPORIDIUM INFECTION IN IMMUNOCOM PROMISED AND IMMUNOCOMPETENT CASES BY STOOL ANALYSIS VERSUS COPRO-ELISA

PARASITOLOGICAL ASSESSMENT OF DIFFERENT CONCENTRATIONS OF PIPERAZINE CITRATE AGAINST CRYPTOSPORIDIOSIS INFECTION IN BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMISED MICE

Effect of piperazine citrate on experimentally cryptosporidium parvum infected mice